Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study (vol 189, pg 400, 2023)

被引：0
|
作者：
Guardala, Noel A.
机构：
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷 / 03期
关键词：
D O I：
10.1093/bjd/ljad482
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E24 / E26
页数：3
相关论文
共 50 条
  • [21] A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis
    Shefner, Jeremy M.
    Wolff, Andrew A.
    Meng, Lisa
    Bian, Amy
    Lee, Jacqueline
    Barragan, Donna
    Andrews, Jinsy A.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2016, 17 (5-6) : 426 - 435
  • [22] Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
    Low, Jenny G.
    Sung, Cynthia
    Wijaya, Limin
    Wei, Yuan
    Rathore, Abhay P. S.
    Watanabe, Satoru
    Tan, Boon Hian
    Toh, Liying
    Chua, Lion Tee
    Hou, Yan'an
    Chow, Angelia
    Howe, Shiqin
    Chan, Wing Ki
    Tan, Kah Hin
    Chung, Jasmine S.
    Cherng, Benjamin P.
    Lye, David C.
    Tambayah, Paul A.
    Ng, Lee Ching
    Connolly, John
    Hibberd, Martin L.
    Leo, Yee Sin
    Cheung, Yin Bun
    Ooi, Eng Eong
    Vasudevan, Subhash G.
    LANCET INFECTIOUS DISEASES, 2014, 14 (08): : 706 - 715
  • [23] A PHASE III, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF NEUCARDIN™ IN PATIENTS WITH CHRONIC HEART FAILURE
    Gao, Runlin
    Zhang, Jian
    Liu, Heping
    Wang, Lina
    Pang, Xiaohua
    Fu, Lu
    Meng, Fanbo
    Zhou, Mingdong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 668 - 668
  • [24] Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial
    Alavi, Afsaneh
    Prens, Errol P.
    Kimball, Alexa B.
    Frew, John W.
    Krueger, James G.
    Mukhopadhyay, Sutirtha
    Gao, Heli
    Ranganathan, Usha
    Ivanoff, Nathalie B.
    Hernandez Daly, Ana C.
    Zouboulis, Christos C.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (04) : 508 - 518
  • [25] A randomized double-blind placebo-controlled phase 2 study on the efficacy and safety of fasudil in patients with stable angina
    Vicari, RM
    Chaitman, B
    Keefe, D
    Smith, WB
    Chrysant, ST
    Tonkon, MJ
    Bittar, N
    Weiss, RJ
    Thadani, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 254A - 254A
  • [26] Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
    Piemonti, Lorenzo
    Landoni, Giovanni
    Voza, Antonio
    Puoti, Massimo
    Gentile, Ivan
    Coppola, Nicola
    Nava, Stefano
    Mattei, Alessia
    Marinangeli, Franco
    Marchetti, Giulia
    Bonfanti, Paolo
    Mastroianni, Claudio Maria
    Bassetti, Matteo
    Crisafulli, Ernesto
    Grossi, Paolo Antonio
    Zangrillo, Alberto
    Desai, Antonio
    Merli, Marco
    Foggia, Maria
    Carpano, Marco
    Schiavoni, Lorenzo
    Monforte, Antonella D'Arminio
    Bisi, Luca
    Russo, Gianluca
    Busti, Fabiana
    Rovelli, Cristina
    Perrotta, Elisabetta
    Goisis, Giovanni
    Gavioli, Elizabeth M.
    Toya, Sophie
    De Pizzol, Maria
    Mantelli, Flavio
    Allegretti, Marcello
    Minnella, Enrico Maria
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (10) : 2437 - 2456
  • [27] Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
    Lorenzo Piemonti
    Giovanni Landoni
    Antonio Voza
    Massimo Puoti
    Ivan Gentile
    Nicola Coppola
    Stefano Nava
    Alessia Mattei
    Franco Marinangeli
    Giulia Marchetti
    Paolo Bonfanti
    Claudio Maria Mastroianni
    Matteo Bassetti
    Ernesto Crisafulli
    Paolo Antonio Grossi
    Alberto Zangrillo
    Antonio Desai
    Marco Merli
    Maria Foggia
    Marco Carpano
    Lorenzo Schiavoni
    Antonella D’Arminio Monforte
    Luca Bisi
    Gianluca Russo
    Fabiana Busti
    Cristina Rovelli
    Elisabetta Perrotta
    Giovanni Goisis
    Elizabeth M. Gavioli
    Sophie Toya
    Maria De Pizzol
    Flavio Mantelli
    Marcello Allegretti
    Enrico Maria Minnella
    Infectious Diseases and Therapy, 2023, 12 : 2437 - 2456
  • [28] EFFICACY AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ROTATOR CUFF TENDINOPATHY: A 24-WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II PROOF-OF-CONCEPT TRIAL
    Millar, N. L.
    Mcinnes, I.
    Mindeholm, L.
    Seroutou, A.
    Praestgaard, J.
    Schramm, U.
    Levitch, R.
    Weber, E.
    Laurent, D.
    Rosen, J.
    Schett, G.
    Roubenoff, R.
    Schieker, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 211 - 212
  • [29] Dupilumab in Patients with Corticosteroid-Dependent Severe Asthma: Efficacy and Safety Results from the Randomized, Double-Blind, Placebo-Controlled Phase 3 LIBERTY ASTHMA VENTURE Study
    Rabe, K. F.
    Nair, P. K.
    Brusselle, G. G.
    Maspero, J. F.
    Castro, M.
    Zhu, H.
    Staudinger, H.
    Pirozzi, G.
    Antoni, C.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [30] Efficacy and safety of dupilumab with concomitant topical corticosteroids in Japanese pediatric patients with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled phase 3 study
    Ebisawa, Motohiro
    Kataoka, Yoko
    Tanaka, Akio
    Nagao, Mizuho
    Laws, Elizabeth
    Mortensen, Eric
    Nawata, Hisakatsu
    Arima, Kazuhiko
    Watanabe, Daisuke
    Lu, Xin
    Maloney, Jennifer
    Dubost-Brama, Ariane
    Bansal, Ashish
    Yahata, Kenji
    ALLERGOLOGY INTERNATIONAL, 2024, 73 (04) : 532 - 542
12345